Recombinant Human Erythropoietin Alfa

Recombinant Human Erythropoietin Alfa (RHEA) is a recombinant form of a naturally occurring hormone called erythropoietin. This hormone is produced by the kidneys and is responsible for stimulating the production of red blood cells in the bone marrow.
RHEA is a combination medication used to treat anemia (low red blood cell count) in patients with chronic kidney disease. It is also used in patients undergoing chemotherapy, and those with certain blood disorders such as aplastic anemia or myelodysplastic syndromes. By increasing the number of red blood cells in the bloodstream, RHEA helps improve oxygen delivery to the body’s tissues and organs, thus alleviating symptoms of anemia and improving overall quality of life.
RHEA is administered through subcutaneous injections, usually once or twice a week. It is important to follow the prescribed dosage and schedule, as well as to monitor for any potential side effects. As with any medication, the benefits and risks should be carefully considered and discussed with a healthcare professional before use.